Fundraising Fox
/People
Sign in

David B. Klein

Founder

Founder and CEO at Click Therapeutics

New York, New York, United States

FoundedClick Therapeutics

Find your path to David

Sign up to see every warm intro you have to David

  • Paths you didn't know you had: your email and LinkedIn already hold routes to David. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

David Benshoof Klein is the founder and CEO of Click Therapeutics, Inc., a company that develops and commercializes software as prescription medical treatments; its products include Rejoyn, developed with Otsuka and FDA-authorized for adjunctive treatment of major depressive disorder symptoms, and CT-132, FDA-authorized for the preventive treatment of episodic migraine. Before founding Click, he was Managing Director at Opus Point Partners, which built and financed companies including Cougar Biotechnology, Chelsea Therapeutics, and TG Therapeutics. He holds a bachelor's degree from Brandeis University, has served as guest faculty at Columbia University, NYU Stern School of Business, and Columbia Business School, and is co-founder of the Eli Klein Gallery.

Founder and CEO at Click Therapeutics

Intro paths

→

In turn, David can intro founders to Click Therapeutics's investors below.

Click Therapeutics's investors · 13

7wire VenturesChicago · $100K – $5M checks · since 2025Accelmed PartnersMiami · since 2021Boehringer Ingelheim Venture FundIngelheim am Rhein · $16.2M checksH.I.G. BioHealth Partnerssince 2025H.I.G. CapitalMiamiH.I.G. HealthBridge PartnersMiami · $5M – $40M checksHealth Catalyst CapitalNew YorkHikma VenturesLondon · $5M checksNational Institutes of Health (NIH)since 2018Omega FundsBoston · since 2018Revelation PartnersSausalito · $5M – $50M checksSanofi VenturesCambridge · $5M checks · since 2021Supernode VenturesNew York · $500K – $1.3M checks

Frequently asked questions

Who is David B. Klein?
David Benshoof Klein is the founder and CEO of Click Therapeutics, Inc., a company that develops and commercializes software as prescription medical treatments; its products include Rejoyn, developed with Otsuka and FDA-authorized for adjunctive treatment of major depressive disorder symptoms, and CT-132, FDA-authorized for the preventive treatment of episodic migraine. Before founding Click, he was Managing Director at Opus Point Partners, which built and financed companies including Cougar Biotechnology, Chelsea Therapeutics, and TG Therapeutics. He holds a bachelor's degree from Brandeis University, has served as guest faculty at Columbia University, NYU Stern School of Business, and Columbia Business School, and is co-founder of the Eli Klein Gallery.
Where does David B. Klein work?
David B. Klein is Founder and CEO of Click Therapeutics.
What companies did David B. Klein found?
David B. Klein founded Click Therapeutics.

Founder mafias

About this profile. Compiled from public sources — Click Therapeutics's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights